Health Wizz Co-Founder, Dr. Nitin Desai, To Assist And Advise Ehave On Mental Health Analytical Platforms
29. Juni 2021 08:30 ET
|
Ehave
MIAMI, June 29, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Nitin...
Dr. Jeffrey Kamlet Internationally Recognized Expert on Cardiac Safety in Ibogaine Treatment Joins Ehave as Chief Medical Officer
15. Juni 2021 09:31 ET
|
Ehave
MIAMI, June 15, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the...
Ehave To Release Vaccine Passport As Part Of Its Medical Passport
03. Juni 2021 09:47 ET
|
Ehave
MIAMI, June 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...
Ehave Expands Dashboard Capabilities to Include Decentralized Trials and Virtual Studies
02. Juni 2021 08:30 ET
|
Ehave
MIAMI, June 02, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, today...
Ehave KetaDASH Subsidiary Commences Data Collection for Potential Patients and Partnering Clinics
20. Mai 2021 06:30 ET
|
Ehave
MIAMI, May 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its KetaDASH...
Ehave, Inc. Announces Engagement of Legal Counsel to Advise on Launch of KetaDASH in Miami Metro Area and across United States; Ehave Creates Path to Revenue Stream
22. April 2021 12:32 ET
|
Ehave
MIAMI, April 22, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the Company...
Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology
16. April 2021 07:30 ET
|
Ehave
MIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to...
Psilocybin Data Study Agreement Reached Between Ehave Inc. and Silo Wellness Using Brain Scientific Mapping Neurocap
23. März 2021 07:00 ET
|
Ehave
MIAMI, March 23, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors, and Silo Wellness Inc. (CSE: SILO) (“Silo...
Ehave CEO Benjamin Kaplan to be Featured on Psychedelic Spotlight Segment of New to the Street Airing on NewsMax on Sunday March 14th at 10:00 AM EST and Fox Business March 15th at 7:30 PM EST
12. März 2021 12:01 ET
|
Ehave
MIAMI, March 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today CEO and...
Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares to the OTCQB
03. März 2021 08:30 ET
|
Ehave
MIAMI, March 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...